{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T20:09:04Z","timestamp":1769198944657,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81301506; 81271916"],"award-info":[{"award-number":["81301506; 81271916"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013286","name":"Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"crossref","award":["20120131110055; 20130131120067"],"award-info":[{"award-number":["20120131110055; 20130131120067"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"crossref","award":["ZR2013HQ063"],"award-info":[{"award-number":["ZR2013HQ063"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.cca.2014.10.026","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T08:22:24Z","timestamp":1414398144000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125"],"prefix":"10.1016","volume":"439","author":[{"given":"Pei-long","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong-fu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-tao","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.10.026_bb0005","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/S0020-7292(06)60040-4","article-title":"Quality of life considerations in gynecologic cancer. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Penson","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.cca.2014.10.026_bb0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/mcp.R400006-MCP200","article-title":"Progress and challenges in screening for early detection of ovarian cancer","volume":"3","author":"Jacobs","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.cca.2014.10.026_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1525-1438.2005.00441.x","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Bast","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cca.2014.10.026_bb0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jnci\/djj019","article-title":"Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients","volume":"98","author":"Earle","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cca.2014.10.026_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1525-1438.2006.00319.x","article-title":"Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals","volume":"16","author":"Paulsen","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cca.2014.10.026_bb0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/gyno.2001.6460","article-title":"A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?","volume":"84","author":"Carney","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.10.026_bb0035","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1373\/clinchem.2008.105601","article-title":"National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers","volume":"54","author":"Sturgeon","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.10.026_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.10.026_bb0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/AOG.0b013e3182755e14","article-title":"Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial","volume":"121","author":"Partridge","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cca.2014.10.026_bb0050","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases","volume":"57","author":"Escudero","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.10.026_bb0055","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1515\/CCLM.2011.075","article-title":"The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?","volume":"49","author":"Montagnana","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2014.10.026_bb0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1018580324971","article-title":"Perspectives on the significance of altered glycosylation of glycoproteins in cancer","volume":"14","author":"Kim","year":"1997","journal-title":"Glycoconj J"},{"key":"10.1016\/j.cca.2014.10.026_bb0065","first-page":"343","article-title":"Total sialic acid, total protein and total sugar levels in serum and saliva of oral squamous cell carcinoma patients: a case control study","volume":"10","author":"Dhakar","year":"2013","journal-title":"Dent Res J"},{"key":"10.1016\/j.cca.2014.10.026_bb0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1074-5521(97)90253-2","article-title":"Glycosphingolipid antigens and cancer therapy","volume":"4","author":"Hakomori","year":"1997","journal-title":"Chem Biol"},{"key":"10.1016\/j.cca.2014.10.026_bb0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5301\/JBM.2008.576","article-title":"Clinical significance of preoperative serum sialic acid levels in colorectal cancer: utility in the detection of patients at high risk of tumor recurrence","volume":"19","author":"Feijoo-Carnero","year":"2014","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.cca.2014.10.026_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.maturitas.2012.07.016","article-title":"Detection of prostate cancer by sialic acid level in patients with non-diagnostic levels of prostate-specific antigen","volume":"73","author":"Michalakis","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.cca.2014.10.026_bb0085","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1074\/jbc.M111.305334","article-title":"Identification of mono- and disulfated N-acetyl-lactosaminyl Oligosaccharide structures as epitopes specifically recognized by humanized monoclonal antibody HMOCC-1 raised against ovarian cancer","volume":"287","author":"Shibata","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2014.10.026_bb0090","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1021\/pr300656r","article-title":"Proteomic profiling of breast tissue collagens and site-specific characterization of hydroxyproline residues of collagen alpha-1-(I)","volume":"11","author":"Montgomery","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.cca.2014.10.026_bb0095","first-page":"1007","article-title":"ELISA measurement for urinary 3-hydroxyproline-containing peptides and its preliminary application to healthy persons and cancer patients","volume":"30","author":"Saito","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cca.2014.10.026_bb0100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1265\/jjh.49.797","article-title":"Effects of aging on urinary secretion of 3-hydroxyproline and its importance for cancer screening in the elderly with ROC analysis","volume":"49","author":"Bos","year":"1994","journal-title":"Nihon Eiseigaku Zasshi"},{"key":"10.1016\/j.cca.2014.10.026_bb0105","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.7314\/APJCP.2012.13.5.2399","article-title":"Comparison of serum tumor associated material (TAM) with conventional biomarkers in cancer patients","volume":"13","author":"Shu","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.cca.2014.10.026_bb0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7314\/APJCP.2012.13.1.301","article-title":"Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients","volume":"13","author":"Li","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.cca.2014.10.026_bb0115","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1515\/cclm-2012-0642","article-title":"Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids","volume":"51","author":"Kuzmanov","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cca.2014.10.026_bb0120","doi-asserted-by":"crossref","first-page":"e71159","DOI":"10.1371\/journal.pone.0071159","article-title":"Increase in sialylation and branching in the mouse serum N-glycome correlates with inflammation and ovarian tumour progression","volume":"8","author":"Saldova","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2014.10.026_bb0125","first-page":"1773","article-title":"Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer","volume":"25","author":"Molina","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cca.2014.10.026_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000048687","article-title":"S-100 protein serum levels in patients with benign and malignant diseases: false-positive results related to liver and renal function","volume":"23","author":"Molina","year":"2002","journal-title":"Tumour Biol"},{"key":"10.1016\/j.cca.2014.10.026_bb0135","first-page":"609","article-title":"Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up","volume":"30","author":"van Dalen","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.cca.2014.10.026_bb0140","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2008.04.002","article-title":"Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus","volume":"110","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cca.2014.10.026_bb0145","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5468\/ogs.2013.56.4.234","article-title":"Clinical efficacy of serum human epididymis protein 4 as a diagnostic biomarker of ovarian cancer: a pilot study","volume":"56","author":"Chung","year":"2013","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.cca.2014.10.026_bb0150","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ijc.26129","article-title":"Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer","volume":"130","author":"Park","year":"2012","journal-title":"Int J Cancer"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114004574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114004574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T11:14:11Z","timestamp":1589282051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114004574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":30,"alternative-id":["S0009898114004574"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.10.026","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined detection of sialic acid and hydroxyproline in diagnosis of ovarian cancer and its comparison with human epididymis protein 4 and carbohydrate antigen 125","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}